Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftizoxime (250mg) Injection
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
mono
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ceftizoxime 250 mg Injection is a third-generation cephalosporin antibiotic used for the treatment of a wide range of bacterial infections. It is effective against infections of the respiratory tract, urinary tract, skin, and soft tissues.
Ceftizoxime works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria and control of infection. Its broad-spectrum activity ensures effective treatment against various gram-positive and gram-negative organisms.
Common side effects may include fever, headache, nausea, vomiting, diarrhea, and infusion-related reactions such as rash or flushing. Some patients may experience elevated liver enzymes. Rarely, hypersensitivity reactions or severe allergic responses may occur.
Ceftizoxime 250 mg Injection is indicated for the treatment of serious fungal infections such as invasive candidiasis, esophageal candidiasis, and invasive aspergillosis, particularly in patients who are refractory to or intolerant of other antifungal therapies. It works by inhibiting the synthesis of the fungal cell wall, thereby controlling and eliminating infection.
This medication should be administered under strict medical supervision. Regular monitoring of liver function is recommended during treatment. Inform your doctor about any history of liver disease, allergies, or ongoing medications. Complete the full prescribed course for effective results.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep in original packaging and out of reach of children. Use as directed after reconstitution.
Composition : Acetylcysteine (20% w/v) Injection
Composition : Acyclovir (500mg) Injection
Composition : Adrenaline 0.1% w/v Injection
Composition : Ceftazidime (1gm)
Composition : Aztreonam (500mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftriss 250 Injection, containing Ceftizoxime 250mg, has strong demand in the hospital anti-infective segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotic and critical care portfolios.
Medical distributors and agencies can benefit from the consistent hospital demand for third-generation cephalosporin antibiotics used in moderate to severe bacterial infections, respiratory tract infections, urinary tract infections, and post-operative care. Ceftriss 250 Injection helps strengthen a comprehensive anti-infective injectable product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftriss 250 Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted nutraceutical and wellness product range when partnering for Multibolt Capsule distribution.
Medical distributors, stockists, and wholesalers interested in Multibolt Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.